Early opposition to the tax bill among the Senate GOP concerns tax treatment of partnerships and other pass-throughs, the repeal of the ACA individual mandate, and the deficit implications of the plan.

U.S. regulators approved the first medicine with an embedded sensor to help keep track of whether patients with mental illness are adhering to their prescriptions.

Seizing on the Trump administrations deregulation drive, corporate lobbyists are pushing to override state laws on ingredient-disclosure rules and warning labels, including landmark California legislation on potential cancer risks.

Labor's Acosta told a House committee that DOL has already drafted regulations describing how it would handle violations of the best-interest standards.